Distribution of 18F-5-Fluorouracil in tumor-bearing mice and rats
- 31 March 1978
- journal article
- Published by Elsevier in International Journal of Nuclear Medicine and Biology
- Vol. 5 (1) , 19-28
- https://doi.org/10.1016/0047-0740(78)90086-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- One thousand vasectomies: Marian N. Barnes and J. P. Blandy (4: 216, 1973)Urology, 1974
- Adenocarcinomas of stomach, pancreas, liver, and biliary tracts.Survival of 328 patients treated with fluoropyrimidine therapyCancer, 1974
- 5-Fluorouracil and Derivatives in Cancer Chemotherapy ID: In Vivo Enhancement of Antitumor Activity of 5-Fluorouracil (FU) and 5-Fluoro-2ʹ-deoxyuridine (FUDR)Journal of Pharmaceutical Sciences, 1973
- Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinosideCancer, 1972
- Enhancement of tumor growth and immunosuppression in mice with 5- fluorouracilThe Lancet Healthy Longevity, 1972
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964
- Thin-layer chromatography of fluoropyrimidinesMicrochemical Journal, 1964
- Studies on Fluorinated PyrimidinesPublished by Elsevier ,1960
- Studies on fluorinated pyrimidines: VII—the degradative pathwayBiochemical Pharmacology, 1959
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957